Patients with non-small cell lung cancer (NSCLC) taking bevacizumab biosimilars demonstrated equivalent therapeutic efficacy ...

Cetuximab Biosimilar Receives NMPA Approval for RAS/BRAF Wild-Type CRC ...

The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

Study Confirms CT-P42 Therapeutic Equivalence to Reference Aflibercept in DME ...

Study Confirms CT-P42 Therapeutic Equivalence to Reference Aflibercept in DME ...

Cetuximab Biosimilar Receives NMPA Approval for RAS/BRAF Wild-Type CRC ...

On this episode of Not So Different, we explore the Federal Trade Commission’s (FTC) second interim report on pharmacy ...

Cetuximab Biosimilar Receives NMPA Approval for RAS/BRAF Wild-Type CRC ...

Cetuximab Biosimilar Receives NMPA Approval for RAS/BRAF Wild-Type CRC ...

Number 4: The FDA and European Medicines Agency (EMA) granted approval, with interchangeability in the US, to Samsung Bioepis ...